Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

13 févr. 2026 08h32 HE | Source: Moleculin Biotech, Inc.

Moleculin Launches CEO Corner Platform to Share Strategic Insights

CEO Corner segments intended to provide added perspective to press releases, clinical trial developments and pipeline progress Provides interested parties with the ability to connect with the Company...
11 févr. 2026 09h23 HE | Source: Research and Markets

European Pharma Handbook 2026: A Single Source of Accurate, Up-to-date Statistics, Information and Analysis on Prescription Drug Business and Regulatory Environments

Dublin, Feb. 11, 2026 (GLOBE NEWSWIRE) -- The "European Pharma Handbook" directory has been added to ResearchAndMarkets.com's offering. The European Pharma Handbook provides pharmaceutical...
11 févr. 2026 08h44 HE | Source: Research and Markets

USA Pharmaceutical Industry Directory 2026: Comprehensive Intelligence on 4,000+ Pharmaceutical Companies and 8,000+ Senior Executives

Dublin, Feb. 11, 2026 (GLOBE NEWSWIRE) -- The "USA Pharmaceutical Directory" directory has been added to ResearchAndMarkets.com's offering.The USA Pharmaceutical Directory is one of the most...
11 févr. 2026 08h39 HE | Source: Research and Markets

European and USA Pharmaceutical Industry Directory 2026: Comprehensive Access Over 7,500 Pharmaceutical Companies, Providing Key Contacts, Industry Insights, and Potential Business Leads

Dublin, Feb. 11, 2026 (GLOBE NEWSWIRE) -- The "European and USA Pharmaceutical Directory" directory has been added to ResearchAndMarkets.com's offering.This new Directory combines both the whole...
11 févr. 2026 06h16 HE | Source: Research and Markets

Major Pharmaceutical Companies Directory 2026: Vital Insights Into 1,000 Top Global Pharmaceutical and Biotech Companies and 4,000 Names of Senior Management and Board Members

Dublin, Feb. 11, 2026 (GLOBE NEWSWIRE) -- The "Major Pharmaceutical Companies" directory has been added to ResearchAndMarkets.com's offering.Essential for those doing business in the global...
10 févr. 2026 11h16 HE | Source: Research and Markets

Pharmaceutical Company International Directory 2026: 20,000 Pharmaceutical Companies, 30,000 Executives in Over 200 Countries

Dublin, Feb. 10, 2026 (GLOBE NEWSWIRE) -- The "International Directory of Pharmaceutical Companies" directory has been added to ResearchAndMarkets.com's offering.The International Directory of...
28 janv. 2026 04h25 HE | Source: Research and Markets

Continuous Manufacturing for Small Molecule APIs Industry Research 2026 - Global Market Size, Share, Trends, Opportunities, and Forecasts, 2021-2025 & 2026-2031

Dublin, Jan. 28, 2026 (GLOBE NEWSWIRE) -- The "Continuous Manufacturing for Small Molecule APIs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031" has been added to ...
21 janv. 2026 05h23 HE | Source: Research and Markets

Pharma Hub and Patient Access Support Service Market Analysis Report by Service Type, Service Delivery Type and Region with Growth Forecasts, 2025-2033

Dublin, Jan. 21, 2026 (GLOBE NEWSWIRE) -- The "Pharma Hub and Patient Access Support Service Market Size, Share & Trends Analysis Report by Service Type, Service Delivery Type and Region with...
07 janv. 2026 09h42 HE | Source: Research and Markets

Top 1000 Major Pharmaceutical Companies Directory 2026 with Profiles of 4,000 Names of Senior Management and Board Members

Dublin, Jan. 07, 2026 (GLOBE NEWSWIRE) -- The "Top 1000 Major Pharmaceutical Companies 2026" directory has been added to ResearchAndMarkets.com's offering. Essential for those doing business in...
10 déc. 2025 08h30 HE | Source: Moleculin Biotech, Inc.

Moleculin Announces Exercise of Warrants for $6.8 Million Gross Proceeds

HOUSTON, Dec. 10, 2025 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc., (Nasdaq: MBRX) (“Moleculin” or the “Company”), a late-stage pharmaceutical company with a broad portfolio of drug candidates...

Page suivante